论文部分内容阅读
原发性肝癌合并门静脉癌栓栓塞化疗后 ,易引起肝功能衰竭。我们回顾分析了首次超选择性插管栓塞化疗的 32例肝癌合并门静脉癌栓患者的疗效及肝功能变化。材料与方法患者 32例 ,男 2 9例 ,女 3例 ,年龄 36～ 78岁 ,平均 5 7岁 ,经病理学或血清 +影像学检查确诊为原发性肝癌 ,经
After primary hepatocellular carcinoma combined with portal vein cancer embolization and chemotherapy, liver failure can be easily caused. We retrospectively analyzed the efficacy and liver function changes of 32 cases of hepatocellular carcinoma combined with portal vein tumor embolization by first superselective intubation embolization chemotherapy. Materials and Methods 32 patients, 29 males and 3 females, aged 36 to 78 years old, average 5 7 years old, diagnosed as primary liver cancer by pathology or serum + imaging examination.